Form 8-K - Current report:
SEC Accession No. 0001104659-15-046466
Filing Date
2015-06-19
Accepted
2015-06-19 17:00:38
Documents
3
Period of Report
2015-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-14444_18k.htm 8-K 19115
2 EX-3.1 a15-14444_1ex3d1.htm EX-3.1 31023
3 GRAPHIC g144441ke01i001.gif GRAPHIC 5081
  Complete submission text file 0001104659-15-046466.txt   58662
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 15942970
SIC: 2834 Pharmaceutical Preparations